Free Trial

Morgan Stanley (MS) Stock Forecast & Price Target

Morgan Stanley logo
$112.18 +0.49 (+0.44%)
Closing price 03:59 PM Eastern
Extended Trading
$112.84 +0.66 (+0.59%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Morgan Stanley - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
11
Buy
6

Based on 17 Wall Street analysts who have issued ratings for Morgan Stanley in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 11 have given a hold rating, and 6 have given a buy rating for MS.

Consensus Price Target

$131.27
17.01% Upside
According to the 17 analysts' twelve-month price targets for Morgan Stanley, the average price target is $131.27. The highest price target for MS is $156.00, while the lowest price target for MS is $105.00. The average price target represents a forecasted upside of 17.01% from the current price of $112.18.
Get the Latest News and Ratings for MS and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Morgan Stanley and its competitors.

Sign Up

MS Analyst Ratings Over Time

TypeCurrent Forecast
3/11/24 to 3/11/25
1 Month Ago
2/10/24 to 2/9/25
3 Months Ago
12/12/23 to 12/11/24
1 Year Ago
3/12/23 to 3/11/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
6 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
6 Buy rating(s)
Hold
11 Hold rating(s)
11 Hold rating(s)
11 Hold rating(s)
12 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$131.27$131.27$121.80$94.56
Forecasted Upside17.01% Upside-6.16% Downside-4.52% Downside8.76% Upside
Consensus Rating
Hold
Hold
Hold
Hold
Remove Ads

MS Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

MS Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Morgan Stanley Stock vs. The Competition

TypeMorgan StanleyFinance CompaniesS&P 500
Consensus Rating Score
2.35
2.52
2.53
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside17.06% Upside36.32% Upside20.58% Upside
News Sentiment Rating
Positive News

See Recent MS News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
1/21/2025UBS Group
4 of 5 stars
Brennan Hawken
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$130.00 ➝ $140.00+2.81%
1/17/2025Barclays
3 of 5 stars
Jason Goldberg
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$155.00 ➝ $156.00+13.27%
1/17/2025Bank of America
3 of 5 stars
Michael Carrier
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$146.00 ➝ $153.00+11.43%
1/17/2025Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Glenn Schorr
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOutperform ➝ Outperform$140.00 ➝ $150.00+10.15%
1/17/2025Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Konrad
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetMarket Perform ➝ Market Perform$138.00 ➝ $145.00+6.78%
1/13/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kian Abouhossein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$104.00 ➝ $108.00-12.61%
11/26/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Martinez
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
11/26/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$128.00 ➝ $131.00-2.00%
11/25/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$105.00 ➝ $135.00+0.52%
11/15/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Mayo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Equal Weight$107.00 ➝ $142.00+7.22%
10/17/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Ramsden
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$106.00 ➝ $121.00+0.82%
10/17/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetSector Perform ➝ Sector Perform$108.00 ➝ $122.00+1.66%
10/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$120.00 ➝ $135.00+12.69%
7/18/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMarket Perform
7/18/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$116.00 ➝ $118.00+10.42%
7/17/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
4/16/2024Cfra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$97.00 ➝ $108.00+20.82%
11/28/2023Societe Generale
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$80.00+2.63%
11/20/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$85.00+5.88%
10/23/2023Odeon Capital Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$79.15+8.72%
10/20/2023Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Peer Perform
8/1/2023Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$85.00 ➝ $90.00-1.70%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 11:48 PM ET.


Should I Buy Morgan Stanley Stock? MS Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, March 4, 2025. Please send any questions or comments about these Morgan Stanley pros and cons to contact@marketbeat.com.

Morgan Stanley
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Morgan Stanley:

  • The recent earnings report showed an earnings per share (EPS) of $2.22, significantly exceeding analysts' expectations of $1.54, indicating strong financial performance.
  • With a current stock price of $121.32, Morgan Stanley is trading below its 1-year high of $142.03, suggesting potential for price appreciation.
  • The company has announced a quarterly dividend of $0.925, which translates to an annualized yield of 3.05%, providing a steady income stream for investors.
  • Institutional investors hold 84.19% of the stock, indicating strong confidence from large financial entities in Morgan Stanley's future prospects.
  • Analysts have recently raised their price targets for Morgan Stanley, with some predicting a target as high as $156.00, reflecting positive sentiment in the market.

Morgan Stanley
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Morgan Stanley for these reasons:

  • The stock has experienced a significant decline, trading down $7.82 recently, which may indicate volatility and potential risks in the short term.
  • Insider selling has been observed, with key executives reducing their holdings, which could signal a lack of confidence in the company's near-term performance.
  • The company's debt-to-equity ratio stands at 3.14, suggesting a high level of debt compared to equity, which may pose risks during economic downturns.
  • Despite strong earnings, the market's overall sentiment can be influenced by broader economic conditions, which may affect stock performance.
  • Analysts have a consensus rating of "Hold," indicating that while there is potential, there is also caution among experts regarding immediate investment.

MS Forecast - Frequently Asked Questions

According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Morgan Stanley is $131.27, with a high forecast of $156.00 and a low forecast of $105.00.

17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Morgan Stanley in the last twelve months. There are currently 11 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MS, but not buy additional shares or sell existing shares.

According to analysts, Morgan Stanley's stock has a predicted upside of 17.01% based on their 12-month stock forecasts.

Morgan Stanley has been rated by research analysts at Bank of America, Barclays, Evercore ISI, JPMorgan Chase & Co., Keefe, Bruyette & Woods, and UBS Group in the past 90 days.

Morgan Stanley also publishes sell-side equities research reports and recommendations about other companies, which can be viewed at its brokerage rating page.

Analysts like Morgan Stanley less than other "finance" companies. The consensus rating for Morgan Stanley is Hold while the average consensus rating for "finance" companies is Moderate Buy. Learn more on how MS compares to other companies.


This page (NYSE:MS) was last updated on 3/11/2025 by MarketBeat.com Staff
From Our Partners